Can planned CD34+ stem cell boost prevent poor graft function after peripheral blood haploidentical hematopoietic transplantation?

Leuk Lymphoma. 2021 Mar;62(3):749-751. doi: 10.1080/10428194.2020.1839657. Epub 2020 Nov 2.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, CD34
  • Graft vs Host Disease* / etiology
  • Graft vs Host Disease* / prevention & control
  • Hematopoietic Stem Cell Transplantation* / adverse effects
  • Humans
  • Peripheral Blood Stem Cell Transplantation* / adverse effects
  • Transplantation Conditioning
  • Transplantation, Haploidentical
  • Transplantation, Homologous

Substances

  • Antigens, CD34